Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early β-Amyloid Accumulation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Overwhelming evidence indicates that the effects of β-amyloid (Aβ) are dose dependent both in vitro and in vivo, which implies that Aβ is not directly detrimental to brain cells until it reaches a threshold concentration. In an effort to understand early Alzheimer's disease (AD) pathogenesis, this study focused on the effects of subthreshold soluble Aβ and the underlying molecular mechanisms in murine microglial cells and an AD transgenic mouse model. We found that there were two phases of dose-dependent Aβ effects on microglial cells: at the threshold of 5 μ m and above, Aβ directly induced tumor necrosis factor-α (TNF-α) release, and at subthreshold doses, Aβ indirectly potentiated TNF-α release induced by certain G-protein-coupled receptor (GPCR) activators. Mechanistic studies revealed that subthreshold Aβ pretreatment in vitro reduced membrane GPCR kinase-2/5 (GRK2/5), which led to retarded GPCR desensitization, prolonged GPCR signaling, and cellular hyperactivity to GPCR agonists. Temporal analysis in an early-onset AD transgenic model, CRND8 mice, revealed that the membrane (functional) GRK2/5 in brain cortices were significantly reduced. More importantly, such a GRK abnormality took place before cognitive decline and changed in a manner corresponding with the mild to moderate soluble Aβ accumulation in these transgenic mice. Together, this study not only discovered a novel link between subthreshold Aβ and GRK dysfunction, it also demonstrated that the GRK abnormality in vivo occurs at prodromal and early stages of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 1×
“…effects, such as cytotoxicity and glial activation (Yankner et al., 1989; Iversen et al., 1995; Meda et al., 1995; Suo et al., 1997), whereas the recent trend appears to favor a pathogenic role of soluble A (Walsh et al., 1997, 2002; Crawford et al., 1998b; Hartley et al., 1999; Lue et al., 1999).”
BackgroundActivation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“Tg-CRND8 mice on a C57BL/6 ϫ C3H/He mixed genetic background (Chishti et al., 2001) were weaned, genotyped, and single housed by age 4 –5 weeks before they were entered into this study.”
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 6×
“Because receptors for both phenylephrine and ET-1 are also GPCRs, it would be interesting to know whether the A -impaired GPCR desensitization by GRKs also underlies the A vasoactivity.”
BackgroundInfluentialStanciu, M., Wang, Y., Kentor, R., Burke, N., Watkins, S., Kress, G., Reynolds, I., Klann, E., Angiolieri, M. R., Johnson, J. W., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12200 · Cited by 539
Smith, D. H., Nakamura, M., McIntosh, T. K., Wang, J., Rodríguez, A., Chen, X.-H., Raghupathi, R., Saatman, K. E., Clemens, J., Schmidt, M. L., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65643-x · Cited by 143
Cited by
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 494
G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
Gurevich, E. V., Tesmer, J. J. G., Mushegian, A., & Gurevich, V. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.08.001 · Cited by 423
Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P., Savage, G., Ng, S., Ackermann, U., Cowie, T. F., Currie, J., Chan, S. G., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.008 · Cited by 292
HT22 hippocampal neuronal cell line possesses functional cholinergic properties
Liu, J., Li, L., & Suo, W. Z. (2009) · Life Sciences · doi:10.1016/j.lfs.2008.12.008 · Cited by 223
Transcription factor Sp1 dysregulation in Alzheimer's disease
Citron, B. A., Dennis, J. S., Zeitlin, R. S., & Echeverria, V. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21695 · Cited by 116
“Phosphorylation/dephosphorylation regulation associated with this pathway has been described elsewhere (Suo et al., 2004; Echeverria et al., 2005).”
BackgroundSelf-citation
Metadata
- Authors
- Suo, Z., Wu, M., Citron, B. A., Wong, G. T., & Festoff, B. W.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-03-31
- Volume
- 24
- Issue
- 13
- Pages
- 3444-3452
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2114226569
- Cited by
- 75
- References
- 6
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early β-Amyloid Accumulation. https://app.cochat.ai/papers/10.1523/jneurosci.4856-03.2004
- The paper
- Suo, Z., Wu, M., Citron, B. A., Wong, G. T., & Festoff, B. W. (2004). Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early β-Amyloid Accumulation. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4856-03.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.